symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
SXTP,0.7776,0,416492,4509722,0,0.67-8.65,0.0366,"60 Degrees Pharmaceuticals, Inc.",USD,0001946563,,,NASDAQ Capital Market,NASDAQ,Biotechnology,https://60degreespharma.com,"60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.",Dr. Geoffrey Stuart Dow,Healthcare,US,2,202-327-5422,1025 Connecticut Avenue NW,Washington,DC,20036,,0,https://financialmodelingprep.com/image-stock/SXTP.png,2023-07-12,True,False,True,False,False
